CHA Releases Advocacy Materials for 2024
What’s happening: New and updated advocacy materials are available for your use.
What else to know: Each packet contains an infographic, key messages, and an issue brief.
What’s happening: New and updated advocacy materials are available for your use.
What else to know: Each packet contains an infographic, key messages, and an issue brief.
What’s happening: CHA will host a complimentary, members-only webinar on Jan. 8 at 3 p.m. (PT) to discuss how the Office of Health Care Affordability (OHCA) will conduct cost and market impact reviews (CMIRs).
What else to know: Registration is required to attend.
What’s happening: OHCA ended 2023 with a proposed preliminary spending target of 3% annually for five years and it finalized cost and market impact review regulations.
What else to know: OHCA’s policy development and implementation is expected to accelerate in 2024, specifically related to the adoption of an initial health care spending target.
What’s happening: On Dec. 1, CHA submitted a comment letter on the Office of Health Care Affordability’s (OHCA) total health care expenditure draft regulations.
What else to know: These regulations will determine how health spending is attributed to providers and who will be accountable under the statewide spending target.
What’s happening: On Nov. 28, the Office of Health Care Affordability (OHCA) released a revised version of the cost and market impact review regulations, alongside an accompanying notice. What else to know: The final regulations are expected to be effective on Jan. 1, 2024, for transactions intended to be completed on or after April 1,...
What’s happening: Draft regulations outline how spending will be tracked for monitoring performance against the spending target.
What else to know: Stakeholders can provide written comments (due Dec. 1) and public comment at a Nov. 14 workshop.
This week, CHA shared two letters with the Office of Health Care Affordability (OHCA).
Earlier this week, the Office of Health Care Affordability released a revised draft regulation on the cost and market impact review process. The revised draft regulations include several notable improvements compared to the prior version, most notably exempting from review transactions in the usual and regular course of business and establishing an expedited review process...
Earlier this week, CHA commented on the June 2023 meetings of the Health Care Affordability Board and Advisory Committee. The letter focuses on the office’s market oversight functions, as well as key issues related to the office’s spending targets and data collection efforts.